Navigation Links
Life Sciences Discovery Fund advances latest research proposals

Seattle (September 17, 2008) Ten Washington State-based life sciences research teams will progress to the interview round in the Life Sciences Discovery Fund's latest grants competition, "Innovative Programs to Advance Health Research." A total of up to $20 million in funding is available in this competition. Funding in this competition will help Washington research organizations and institutions launch new programs of research.

Expert review of proposals in this competition occurs in two stages: a panel review of all proposals followed by interviews of a subset of applicants chosen by the Life Sciences Discovery Fund's Board of Trustees at its September 16, 2008 meeting. All proposals are reviewed for: their scientific, technical and organizational merit; the importance of the research to health and health care; and the potential for the research to create economic returns to Washington State. The ten principal investigators and programs selected for interviews are:

  • Gwenn Garden, "Neurotherapeutics Evaluation Center," University of Washington
  • Mary Larimer, "Center for the Study of Health and Risk Behavior," University of Washington
  • Thomas Rea, "Program to Integrate Technology and Cardiac Arrest Resuscitation," King County (Washington) Department of Public Health
  • Karin Rodland, "Integrated Program in Chronic Pulmonary Disease," Battelle, Pacific Northwest Division
  • John Roll, "Program of Excellence in Rural Mental Health and Substance Abuse Treatment," Washington State University
  • Lawrence Corey, "Washington Vaccine Alliance," Fred Hutchinson Cancer Research Center
  • Patrick Stayton, "Center for Intracellular Delivery of Biologics," University of Washington
  • Jonathan Himmelfarb, "Development of a Chronic Kidney Disease Collaborative," University of Washington
  • Beverly Torok-Storb, "Cell-Based Therapies Through Reprogramming and Cell Fate Control," Fred Hutchinson Cancer Research Center
  • Matthew O'Donnell, "Molecular Imaging and Therapy Using Ultrasound," University of Washington

The interviews will be conducted on November 12-13, 2008 in Seattle, Washington. Final awardee selection by the Life Sciences Discovery Fund Board of Trustees will occur on December 16, 2008.

Funding for this grant competition comes from Washington's allocation of bonus payments under the Master Tobacco Settlement Agreement, revenues arising from multi-state litigation with tobacco product manufacturers.


Contact: Dianne Needham
Life Sciences Discovery Fund

Related biology news :

1. UCI receives $5M from Edwards Lifesciences
2. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
3. Computational mathematical sciences receives NSF grant for undergraduate research
4. Widespread support for nonembryonic stem cell research, VCU Life Sciences Survey shows
5. A special issue of the International Journal of Plant Sciences
6. Media advisory -- 2008 Ocean Sciences Meeting
7. 2008 Ocean Sciences Meeting -- media advisory 2
8. Outstanding undergraduates recognized in agronomy, crop, soil, and environmental sciences
9. Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows
10. UT Southwesterns Mangelsdorf elected to National Academy of Sciences
11. UMass Medical Schools Craig Mello elected to American Academy of Arts and Sciences
Post Your Comments:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, ā€œClinical Trials Patient Recruitment and Retention Tips.ā€ ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: